Rare diseases
Investigational molecules
Locations
Back to Germany43 clinical trials in Georgsmarienhütte, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced non-small cell lung cancer treatment, specifically targeting patients with ALK-positive mutations. The research evaluates cutting-edge therapeutic approaches for better patient outcomes.
These studies aim to assess the effectiveness of brigatinib compared to other second-generation treatments, particularly in cases where traditional therapies may have limited success.
Research centered on deep phenotyping approaches to understand treatment responses in lung cancer patients. This work represents a significant advancement in personalized cancer care strategies.
The studies focus on developing more precise treatment protocols for patients with specific genetic markers, advancing the field of targeted cancer therapy.
Clinical investigations comparing first-line treatment options for advanced lung cancer, with particular attention to progression-free survival rates in treated patients.
The research aims to establish optimal treatment sequences for patients with locally advanced or metastatic lung cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
